Last updated: January 22, 2024
Sponsor: Frank Bochmann
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Vision Loss
Eye Disorders/infections
Astigmatism
Treatment
Marking of the intended axis of IOL-Implantation manually with an ink and marking device on the surface of the eye
Clinical Study ID
NCT05750862
2023_D0001
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients scheduled for cataract surgery who opt for a femtolaser-assisted cataractsurgery (FLACS) and Implantation of a toric intraocular lens. (both are extra optionsnot covered by the insurance)
- Corneal astigmatism more than 1.o diopters confirmed in a measurement of cornealtopography (Pentacam and Cassini topography devices)
Exclusion
Exclusion Criteria:
- Earlier corneal or intraocular refractive interventions (C-TEN, Lasik…)
- Irregular corneal astigmatism
- Corneal pathologies associated with ectasia and/or irregular astigmatism (Pterygium,Keratoconus, pellucide marginal degeneration…)
- Earlier intraocular or ocular surface involving surgeries
- Severe dry eye disease
- Contraindication of performing cataract surgery under topical anaesthesia
Study Design
Total Participants: 30
Treatment Group(s): 1
Primary Treatment: Marking of the intended axis of IOL-Implantation manually with an ink and marking device on the surface of the eye
Phase:
Study Start date:
March 20, 2023
Estimated Completion Date:
June 01, 2024
Study Description
Connect with a study center
Eye Clinic, Cantonal Hospital of Lucerne
Lucerne, 6000
SwitzerlandSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.